Reports

Ideas That Generate Results

Global Vaccine Market Forecast to 2012

Global Vaccine Market Forecast to 2012

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Oct, 2010| No. of Pages : 150

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1500.00
CD-ROM Mail Delivery
US$ 1700.00
Hard Copy Mail Delivery
US$ 1700.00
Electronic Access - Multi-User License
US$ 2000.00

1. Analyst View

2. Research Methodology

3. Market Overview

4. Key Market Drivers
    4.1 Improved Routine Immunization
    4.2 New Vaccine Introduction
    4.3 High Investments
    4.4 Support from Government and NGOs

5. Emerging Trends
    5.1 Cancer Vaccines: Gaining Popularity
    5.2 Collaborations in Vaccine Industry
    5.3 Grants: Raising Support

6. Industry Performance and Future Trends

7. Major Vaccine Segments
    7.1 Basic Pediatrics
    7.2 Enhanced Pediatrics
    7.3 Proprietary Pediatrics
    7.4 Adult Vaccines

8. Pediatric Vaccines
    8.1 Pneumococcal
    8.2 Polio
    8.3 Varicella
    8.4 Meningococcal
    8.5 Rotavirus
    8.6 DTP
    8.7 Measles, Mumps & Rubella (MMR)
    8.8 Tuberculosis

9. Adult/Travel & Therapeutic Vaccines
    9.1 Hepatitis B
    9.2 Malaria
    9.3 Yellow Fever
    9.4 Rabies
    9.5 Japanese Encephalitis
    9.6 Typhoid
    9.7 West Nile
    9.8 HIV
    9.9 Cancer
    9.10 Influenza

10. Key Geographical Markets
    10.1 US
           10.1.1 Market Overview
           10.1.2 Key Players
           10.1.3 Product Portfolio
    10.2 Europe
           10.2.1 Market Overview
           10.2.2 Key Players
           10.2.3 Product Portfolio
    10.3 China
           10.3.1 Market Overview
           10.3.2 Key Players
           10.3.3 Product Portfolio
    10.4 India
           10.4.1 Market Overview
           10.4.2 Key Players
           10.4.3 Product Portfolio
    10.5 Japan
           10.5.1 Market Overview
           10.5.2 Key Players
           10.5.3 Product Portfolio
    10.6 Brazil
           10.6.1 Market Overview
           10.6.2 Key Players
           10.6.3 Product Portfolio

11. Investment Risk in Vaccine Industry
    11.1 High R&D Cost
    11.2 Lack of Infrastructure for Trials and Manufacturing
    11.3 Vaccine Supply
    11.4 Ineffective Distribution

12. Key Mergers & Acquisitions

13. Key Vaccine Brands Forecast to 2012

14. Competitive Landscape
    14.1 Vaccine Majors
           14.1.1 Sanofi-Aventis
           14.1.2 Novartis
    14.2 Biotech-focused Vaccine Companies
           14.2.1 GSK
           14.2.2 Pfizer
    14.3 Domestic-focused Vaccine Companies
           14.3.1 Merck & Co.

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.